MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,627,654 | -61.4% | 5,218,625 | -0.0% | 0.11% | -56.3% |
| Q2 2023 | $17,171,908 | -2.8% | 5,219,425 | +21.4% | 0.24% | -4.3% |
| Q1 2023 | $17,671,434 | -29.6% | 4,299,619 | +0.4% | 0.26% | -23.1% |
| Q4 2022 | $25,096,036 | -9.1% | 4,282,600 | +4.9% | 0.33% | -15.9% |
| Q3 2022 | $27,599,000 | +53.4% | 4,082,600 | +4.8% | 0.40% | +55.9% |
| Q2 2022 | $17,996,000 | +14.1% | 3,895,200 | -1.5% | 0.25% | +38.8% |
| Q1 2022 | $15,777,000 | -39.1% | 3,954,000 | -5.0% | 0.18% | -31.5% |
| Q4 2021 | $25,900,000 | -35.5% | 4,164,000 | -2.3% | 0.27% | -34.6% |
| Q3 2021 | $40,181,000 | +0.6% | 4,261,000 | +44.9% | 0.41% | +4.6% |
| Q2 2021 | $39,939,000 | -13.4% | 2,941,000 | +3.2% | 0.39% | -20.1% |
| Q1 2021 | $46,113,000 | -10.0% | 2,850,010 | +48.0% | 0.49% | -16.9% |
| Q4 2020 | $51,251,000 | – | 1,926,010 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |